• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Fake Weight Loss Drugs: Growing Threat to Consumer Health

Feature
Podcast

In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.

UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:

  • Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks
  • What can be done to raise awareness among consumers about the dangers of counterfeit medications
  • Ways increase access to legitimate weight loss medications, especially for those in underserved communities
  • and much more!
Recent Videos
Related Content